Below are the most recent publications written about "Immunoassay" by people in Profiles.
-
Burns BA, Shaw CA, Chandra M, Forconi CS, Moormann AM, Konduri V, Tubman VN, Decker WK. Comprehensive normalization and binary classification methods for enhanced sensitivity and reproducibility in Luminex assay quantitation. J Immunol Methods. 2025 Mar; 538:113826.
-
Uljon S, Tolan NV, Mahowald GK, Khaliq T, Urwiller ED, Fernandes MD, Basu SS, Kang P, Erickson TB, Hayes BD, Chai PR, Melanson SEF. Performance of a Norfentanyl Immunoassay in Specimens with Low Concentrations of Fentanyl and/or Norfentanyl. J Appl Lab Med. 2024 Sep 03; 9(5):895-904.
-
Yang J, Barbhuiya MA, Hamilton C, Robyak K, Zhu Y. Analytical and Clinical Validation of an Automated Microfluidic Interleukin-6 Immunoassay. Ann Clin Lab Sci. 2024 May; 54(3):388-393.
-
Pratt GW, Platt M, Velez A, Rao LV. A Comparison of Lyme Serological Testing Platforms with a Panel of Clinically Characterized Samples from Various Stages of Lyme Disease. J Appl Lab Med. 2022 Oct 29; 7(6):1445-1449.
-
Barbhuiya MA, Neibauer T, Saylor E, Zhu Y. Comparison of Performance between the Elecsys 4th and 5th Generation STAT Cardiac Troponin T Immunoassays. Ann Clin Lab Sci. 2022 Jul; 52(4):628-633.
-
Murray LP, Govindan R, Mora AC, Munro JB, Mace CR. Antibody affinity as a driver of signal generation in a paper-based immunoassay for Ebola virus surveillance. Anal Bioanal Chem. 2021 Jun; 413(14):3695-3706.
-
Kerensky T, LaRochelle M, Fan SL, Kosakowski S, Wason K, Walley AY. Non-prescription Fentanyl Positive Toxicology: Prevalence, Positive Predictive Value of Fentanyl Immunoassay Screening, and Description of Co-substance Use. J Addict Med. 2021 04 01; 15(2):150-154.
-
?nal B, Camci-Unal G, Mahmud K. Paper-Based Microfluidic Devices: Low-Cost Platforms for Rapid Biochemical Detection. Mil Med. 2021 01 25; 186(Suppl 1):716-721.
-
Cimadamore A, Massari F, Santoni M, Lopez-Beltran A, Cheng L, Scarpelli M, Montironi R, Moch H. PD1 and PD-L1 Inhibitors for the Treatment of Kidney Cancer: The Role of PD-L1 Assay. Curr Drug Targets. 2020; 21(16):1664-1671.
-
Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, Curry SJ, Doubeni CA, Epling JW, Kubik M, Landefeld CS, Mangione CM, Pbert L, Silverstein M, Simon MA, Tseng CW, Wong JB. Screening for HIV Infection: US Preventive Services Task Force Recommendation Statement. JAMA. 2019 Jun 18; 321(23):2326-2336.